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Background: Despite the accumulating genetic and molecular research into hypertrophic cardiomyopathy (HCM), it remains unclear how this 
condition develops and worsens pathologically and clinically in terms of the genetic-environmental interactions. Establishing human disease models 
for HCM would help us to clarify the disease mechanisms. Patient-specific induced pluripotent stem cells (iPSC) thus hold much promise for this 
task.
methods: We generated iPSCs from three patients with HCM and three healthy-control subjects. To identify candidate disease-promoting 
environmental factors, the cardiomyocytes differentiated from the each iPSC line were stimulated by several cardiomyocyte hypertrophy-promoting 
factors. The HCM pathological phenotypes were examined based on the morphological properties, such as cell size and intracellular myofilament 
structures, in randomly chosen cardiac troponin-T-positive single cardiomyocytes. Moreover, high-speed video imaging with motion vector prediction 
algorithm revealed physiological contractile dynamics in the iPSC-derived single cardiomyocytes.
results: Control- and HCM-iPSC-derived cardiomyocytes were similar under the basal condition in pathological features and contractile dynamics. 
However, only the HCM-iPSC-derived cardiomyocytes showed pathological phenotypes such as cardiomyocyte hypertrophy and increased intracellular 
myofilament disorganization in the presence of endothelin-1 (ET-1) induction with a dose-dependent manner. Physiological analyses revealed that 
self-beating HCM-iPSC-derived cardiomyocytes stimulated by ET-1 showed variable contractile directions. Finally, inhibiting the endothelin type-A 
receptor rescued these deleterious effects.
conclusions: Interactions between genetic backgrounds and the environmental factor, ET-1, promote the HCM pathological phenotypes and 
contractile variability in iPSC-derived cardiomyocytes. Our results may push ahead with the developments of novel therapeutic strategy focused on 
the underlying pathogenesis of HCM.
